ADIPOQ and Graves disease: Graves’ disease is an autoimmune thyroid disease commonly presenting as primary hyperthyroidism (rarely as euthyroid or hypothyroid Graves’ disease due to high levels of thyroid-stimulating blocking antibodies) resulting in alterations of body composition, insulin sensitivity, adiponectin levels and BAT function [6–10,15–18].